The combination of 1,25(OH)2D and 1,25(OH)2D was found to regulate Th17 activity and synovial inflammation in patients with RA and potentially in patients with other Th17-mediated inflammatory diseases, suggesting that activation of VDR signaling may be more valuable than current TNF-neutralization strategies [104]. The gene discussed is VDR; the disease is rheumatoid arthritis.